Daily Health News Issue # 427 for 2/18/2026

Editor's Notes:

  • Wall St Journal investigated United Healthcare's CEO and potential conflicts of interest in his investments.
  • Separately, United Healthcare reports that claims for younger workers are going up in part due to not seeking primary care early.
  • RFK may be heading to a conflict with the MAHA movement over regulation of ultra-processed foods – he may not clamp down as much as Make America Health Again folks would like
  • Blue Cross & Blue Shield plans settled class action antitrust suit and will pay out over $2.5 billion.

See you tomorrow.

See our "top articles" list below. For a synoposis of all 44 articles curated today, see further below, and to see each of these articles listed with short summary just click here.

Click here to keep those cards and letters coming…  including if you want to – gasp! – unsubscribe (please don't!)

Audio/Video

Today's Quote:

“Everyone should be skeptical of any medical intervention. I’m not anti-vaccine; I just want good science and informed choice, not blanket mandates.” … â€“ Bill Maher, summarizing his stance on vaccines and healthcare, mid‑2020s

Today's Top Articles

Of the 44 articles curated today, here are the top 6 in our judgment:

Article_Title Article_Takeaway
Musk declares victory with Medicaid data release Elon Musk celebrates the release of Medicaid data, claiming it will expose fraud, while critics fear it’s a diversion from budget cuts.
RFK: FDA “will act on” ultra-processed foods petition HHS Secretary RFK Jr. says the Trump admin. will respond to a petition to overhaul regulations on ultra-processed foods, but action specifics remain unclear.
Are you owed cash? Blue Cross Blue Shield paying $2.6 billion after class-action lawsuit Blue Cross Blue Shield will distribute $2.67 billion to affected subscribers in 2026 after reaching a settlement in an antitrust class action lawsuit.
UnitedHealth Chief Made Private Side Bets on Healthcare Startups UnitedHealth’s CEO Stephen Hemsley made undisclosed private investments in healthcare startups, raising conflict-of-interest concerns.
RFK Jr.’s Next Overhaul: America’s Baby Formula Guidelines The Trump administration’s review of infant formula ingredients is unlikely to remove seed oils despite demands from the MAHA movement.
Claims for younger adults are on the rise: UnitedHealthcare, HAC study A UnitedHealthcare/HAC study finds claims for younger workers are rising faster than for boomers, driven by factors like deferred primary care.

Today's Graphic



Layoffs in Insurance Industry 2025-2026 (Source: Beckers 1/26).  See below or click here 



Today's Graphic

Today's Digest

Here is a summary of all 44 articles curated today into the Competitive Research Analytics Platform for 2/18/2026:

 The healthcare landscape is defined by rapid AI integration, financial turbulence, and intensifying policy debates. Major insurers like UnitedHealth and Humana face headwinds—UnitedHealth's CEO is under scrutiny for undisclosed startup investments, while Humana projects lower earnings as Medicare Advantage enrollment growth slows to just 3%. Humana did complete its CenterWell acquisition of Florida-based MaxHealth, signaling continued payvider consolidation. Blue Cross Blue Shield's $2.67 billion antitrust settlement underscores persistent legal and competitive pressures across the payer sector.

AI is emerging as a double-edged sword: insurers deploy it to cut costs, potentially eroding provider trust, while health systems like Sutter Health and Mayo Clinic partner with startups to embed AI into EHRs and digital front doors. Blockchain is proposed as a privacy safeguard for AI-driven data. Medicaid fraud cases in Ohio, Louisiana, and Virginia highlight ongoing waste concerns, even as Elon Musk's DOGE pushes data transparency critics call a distraction from looming budget cuts.

Rural health remains fragile—Nebraska and Texas receive federal transformation funds, but low reimbursement rates and regulatory barriers threaten PACE program expansion. The MAHA movement influences FDA scrutiny of infant formula and ultra-processed foods, while RFK Jr.'s vaccine skepticism drives manufacturers to slash jobs and research. Employer-sponsored benefits are evolving with GLP-1 drug access via telehealth and anticipatory benefits models. Mental health, gun violence prevention, rising younger-worker claims, and CRISPR gene therapy advances round out a turbulent period of disruption and uncertainty.

See back issues of Daily C.R.A.P. on our website right here in the archive.

As of today, C.R.A.P. now has 199 subscribers

Want to drop us a line? E-Mail Us

Click here for ALL articles added to C.R.A.P. in the past 24 hours

For a short tour of the C.R.A.P. Newsroom, click here! 

Similar Posts

Leave a Reply